Clinical Study

MRI for Assessing Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer Using DCE-MR and DW-MR Data Sets: A Preliminary Report

Table 2

Patient characteristics with volumetric change for individual patient.

Patient numberAgepTpNTRG(C) change [%](DCE) change [%](DWI) change [%]

17420437,1033,2838,86
25010270,7691,3461,08
375103−96,5029,8836,67
45410261,2267,40−5,60
55020277,6535,0781,40
65800152,3646,527,69
75710353,18−3,7162,42
86700180,3470,5772,33
97011259,9939,5946,72
107520277,8178,2122,49
11782138,85−38,501,51
126820320,2027,4218,58
134800192,8486,5692,89
14442132,3721,723,00
155940494,938,5124,50
1660102−4,5228,5239,50
176320321,7313,52−86,38
185820435,39−2,5743,52
194420466,0134,0822,63
206331428,053,26−77,05
216921248,5144,3264,58
227621242,1768,1925,73
237200185,5879,3484,50
246120414,12−83,35−45,41
2564314−45,7520,6421,25
265830344,5118,9428,28
277620250,7260,6136,40
287720413,1675,04−16,52
2957011−23,7312,4549,65

Note: pT = pathological T stage; pN = pathological N stage; (C) = conventional T2-weighted volumetry; (DWI) = diffusion-weighted imaging volumetry; (DCE) = dynamic contrast enhanced volumetry.